Physician profile
Dawn N Deeter
NPI 1154326502
$1,371.60
in general payments reported to CMS, 2019-2025
23 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $65.77 · 2021: $320 · 2022: $138 · 2023: $94.09 · 2024: $240 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $603 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.98 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $200.00 | 2021 | |
| Pfizer INC. | $177.48 | 2019-2023 | |
| Biogen, INC. | $170.47 | 2024-2025 | Zurzuvae |
| Amgen INC. | $168.19 | 2019-2025 | Evenity, Prolia, Prolia |
| Sumitomo Pharma America, INC. | $102.42 | 2024-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $90.08 | 2024 | Ova1 |
| Abbvie INC. | $71.65 | 2020-2022 | |
| Hologic Sales and Service, LLC | $68.78 | 2019-2025 | Aptima, Novasure |
| Astellas Pharma US INC | $45.32 | 2020-2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $43.34 | 2019-2020 | |
| Daiichi Sankyo INC. | $31.39 | 2021 | |
| Allergan, INC. | $30.68 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $24.90 | 2019 | |
| Innovation Technologies INC | $22.25 | 2025 | Irrisept |
| Agile Therapeutics, INC. | $19.08 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $15.85 | 2021 | |
| Medtronic, INC. | $15.08 | 2025 | Truclear |
| Scynexis, INC. | $13.69 | 2022 | |
| Coopersurgical, INC. | $13.61 | 2025 | Paragard T 380a |
| Solventum Corporation | $13.54 | 2024 | Prevena |
| Therapeuticsmd, INC. | $13.11 | 2019 | |
| Smith+Nephew, INC. | $11.34 | 2021 | |
| Organon LLC | $9.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Deeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.